SThree is one of the few global staffing businesses built entirely around science, technology, engineering, and mathematics (STEM) disciplines, with specialist recruitment in the life sciences and pharma sectors forming a core part of its practice. Founded in 1986 and headquartered in London, the group operates across more than 40 countries, placing permanent and contract professionals in roles that span clinical development, regulatory affairs, biostatistics, and pharmacovigilance.
The company trades on the London Stock Exchange under the ticker STEM, a symbol that reflects its single-minded focus on technical talent. Within the pharmaceutical and wider life sciences market, SThree works with global drug developers, contract research organisations, medical device manufacturers, and biotech firms, sourcing specialists for both project-based contract assignments and long-term permanent positions.
Life Sciences & Pharma Recruitment
SThree's life sciences practice addresses persistent talent shortages across clinical research and regulatory functions. The group's brands, including Real Staffing, have longstanding relationships with major pharmaceutical companies and CROs, helping them scale project teams quickly for clinical trials, regulatory submissions, and post-market activities. Contract staffing represents a substantial portion of the business, reflecting the project-driven nature of drug development.
Operationally, SThree combines local market knowledge with an international candidate network, enabling clients to access talent across Europe, North America, and the Asia-Pacific region. The group reports its financial results in alignment with UK corporate governance standards and publishes detailed breakdowns of performance by region and contract type.
Further information is available at sthree.com.